tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Shanghai Henlius Biotech Gains FDA Approval for HLX43 Clinical Trial
PremiumCompany AnnouncementsShanghai Henlius Biotech Gains FDA Approval for HLX43 Clinical Trial
17d ago
Shanghai Henlius Initiates Phase 2 Study for HLX79 in Glomerulonephritis Treatment
Premium
Company Announcements
Shanghai Henlius Initiates Phase 2 Study for HLX79 in Glomerulonephritis Treatment
18d ago
Shanghai Henlius Biotech Schedules Board Meeting to Discuss Interim Results and Dividend
Premium
Company Announcements
Shanghai Henlius Biotech Schedules Board Meeting to Discuss Interim Results and Dividend
23d ago
Shanghai Henlius Biotech Secures EU GMP Certification for Key Biosimilars
PremiumCompany AnnouncementsShanghai Henlius Biotech Secures EU GMP Certification for Key Biosimilars
2M ago
Shanghai Henlius Secures Exclusive Rights for HCB101 Development
Premium
Company Announcements
Shanghai Henlius Secures Exclusive Rights for HCB101 Development
2M ago
Shanghai Henlius Biotech Proposes New Share Option and RSU Schemes
Premium
Company Announcements
Shanghai Henlius Biotech Proposes New Share Option and RSU Schemes
2M ago
Shanghai Henlius Initiates Japanese Study for Cancer Treatment
PremiumCompany AnnouncementsShanghai Henlius Initiates Japanese Study for Cancer Treatment
2M ago
Shanghai Henlius Biotech Initiates Phase 2 Study of HLX43 for Lung Cancer
Premium
Company Announcements
Shanghai Henlius Biotech Initiates Phase 2 Study of HLX43 for Lung Cancer
2M ago
Shanghai Henlius Biotech Gains Approval for H Share Full Circulation
Premium
Company Announcements
Shanghai Henlius Biotech Gains Approval for H Share Full Circulation
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100